Illumination of Parainfluenza Virus Infection and Transmission in Living Animals Reveals a Tissue-Specific Dichotomy

English version České info

The parainfluenza viruses (PIVs) are highly contagious respiratory paramyxoviruses and a leading cause of lower respiratory tract (LRT) disease. Since no vaccines or antivirals exist, non-pharmaceutical interventions are the only means of control for these pathogens. Here we used bioluminescence imaging to visualize the spatial and temporal progression of murine PIV1 (Sendai virus) infection in living mice after intranasal inoculation or exposure by contact. A non-attenuated luciferase reporter virus (rSeV-luc(M-F*)) that expressed high levels of luciferase yet was phenotypically similar to wild-type Sendai virus in vitro and in vivo was generated to allow visualization. After direct intranasal inoculation, we unexpectedly observed that the upper respiratory tract (URT) and trachea supported robust infection under conditions that result in little infection or pathology in the lungs including a low inoculum of virus, an attenuated virus, and strains of mice genetically resistant to lung infection. The high permissivity of the URT and trachea to infection resulted in 100% transmission to naïve contact recipients, even after low-dose (70 PFU) inoculation of genetically resistant BALB/c donor mice. The timing of transmission was consistent with the timing of high viral titers in the URT and trachea of donor animals but was independent of the levels of infection in the lungs of donors. The data therefore reveals a disconnect between transmissibility, which is associated with infection in the URT, and pathogenesis, which arises from infection in the lungs and the immune response. Natural infection after transmission was universally robust in the URT and trachea yet limited in the lungs, inducing protective immunity without weight loss even in genetically susceptible 129/SvJ mice. Overall, these results reveal a dichotomy between PIV infection in the URT and trachea versus the lungs and define a new model for studies of pathogenesis, development of live virus vaccines, and testing of antiviral therapies.

Vyšlo v časopise: Illumination of Parainfluenza Virus Infection and Transmission in Living Animals Reveals a Tissue-Specific Dichotomy. PLoS Pathog 7(7): e32767. doi:10.1371/journal.ppat.1002134
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002134

Souhrn

Zdroje

1. KarronRACollinsPL 2007 Parainfluenza Viruses. 5 ed Philadelphia Lippincott, Williams and Wilkins 1497 1526

2. LambRAParksGD 2007 Paramyxoviridae: The Viruses and Their Replication. 5 ed Philadelphia Lippincott, Williams and Wilkins 1449 1496

3. WilliamsJVEdwardsKMWeinbergGAGriffinMRHallCB 2010 Population-based incidence of human metapneumovirus infection among hospitalized children. J Infect Dis 201 1890 1898

4. ChanockRMParrottRHJohnsonKMKapikianAZBellJA 1963 Myxoviruses: Parainfluenza. Am Rev Respir Dis 88 S152 S166

5. ParrottRHVargoskoAJKimhwBellJAChanockRM 1962 Acute respiratory diseases of viral etiology. III. parainfluenza. Myxoviruses. Am J Public Health Nations Health 52 907 917

6. ParrottRHVargoskoALuckeyAKimHWCummingC 1959 Clinical features of infection with hemadsorption viruses. N Engl J Med 260 731 738

7. MurphyBRCollinsPL 2002 Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics. J Clin Invest 110 21 27

8. MosconaA 2005 Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease. J Clin Invest 115 1688 1698

9. Schaap-NuttAScullMASchmidtACMurphyBRPicklesRJ 2010 Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys. Vaccine 28 2788 2798

10. NagaiY 1999 Paramyxovirus replication and pathogenesis. Reverse genetics transforms understanding. Rev Med Virol 9 83 99

11. FaiscaPDesmechtD 2007 Sendai virus, the mouse parainfluenza type 1: a longstanding pathogen that remains up-to-date. Res Vet Sci 82 115 125

12. DennyFWMurphyTFClydeWAJrCollierAMHendersonFW 1983 Croup: an 11-year study in a pediatric practice. Pediatrics 71 871 876

13. TakimotoTHurwitzJLZhanXKrishnamurthySProuserC 2005 Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus. Viral Immunol 18 255 266

14. DaveVPAllanJESlobodKSSmithFSRyanKW 1994 Viral cross-reactivity and antigenic determinants recognized by human parainfluenza virus type 1-specific cytotoxic T-cells. Virology 199 376 383

15. HurwitzJLSoikeKFSangsterMYPortnerASealyRE 1997 Intranasal Sendai virus vaccine protects African green monkeys from infection with human parainfluenza virus-type one. Vaccine 15 533 540

16. SangsterMHylandLSealyRColecloughC 1995 Distinctive kinetics of the antibody-forming cell response to Sendai virus infection of mice in different anatomical compartments. Virology 207 287 291

17. SlobodKSShenepJLLujan-ZilbermannJAllisonKBrownB 2004 Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy human adults. Vaccine 22 3182 3186

18. JonesBZhanXMishinVSlobodKSSurmanS 2009 Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV. Vaccine 27 1848 1857

19. ZhanXHurwitzJLKrishnamurthySTakimotoTBoydK 2007 Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B. Vaccine 25 8782 8793

20. ZhanXSlobodKSKrishnamurthySLuqueLETakimotoT 2008 Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections. Vaccine 26 3480 3488

21. IidaT 1972 Experimental study on the transmission of Sendai virus in specific pathogen-free mice. J Gen Virol 14 69 75

22. van der VeenJPoortYBirchfieldDJ 1970 Experimental transmission of Sendai virus infection in mice. Arch Gesamte Virusforsch 31 237 246

23. HallCB 2001 Respiratory syncytial virus and parainfluenza virus. N Engl J Med 344 1917 1928

24. HenricksonKJ 2003 Parainfluenza viruses. Clin Microbiol Rev 16 242 264

25. SealyRJonesBGSurmanSLHurwitzJL 2010 Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1. Vaccine 28 6749 6756

26. RudrarajuRSurmanSJonesBSealyRWoodlandDL 2011 Phenotypes and functions of persistent Sendai virus-induced antibody forming cells and CD8+ T cells in diffuse nasal-associated lymphoid tissue typify lymphocyte responses of the gut. Virology 410 429 436

27. LukerKELukerGD 2008 Applications of bioluminescence imaging to antiviral research and therapy: multiple luciferase enzymes and quantitation. Antiviral Res 78 179 187

28. HasanMKKatoAShiodaTSakaiYYuD 1997 Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3′ proximal first locus. J Gen Virol 78 Pt 11 2813 2820

29. ManicassamyBManicassamySBelicha-VillanuevaAPisanelliGPulendranB 2010 Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc Natl Acad Sci U S A 107 11531 11536

30. BukreyevASkiadopoulosMHMurphyBRCollinsPL 2006 Nonsegmented negative-strand viruses as vaccine vectors. J Virol 80 10293 10306

31. GriesenbachUMengCFarleyRChengSHScheuleRK 2008 In vivo imaging of gene transfer to the respiratory tract. Biomaterials 29 1533 1540

32. TokusumiTIidaAHirataTKatoANagaiY 2002 Recombinant Sendai viruses expressing different levels of a foreign reporter gene. Virus Res 86 33 38

33. KatoAKiyotaniKHasanMKShiodaTSakaiY 1999 Sendai virus gene start signals are not equivalent in reinitiation capacity: moderation at the fusion protein gene. J Virol 73 9237 9246

34. SouthamDSDolovichMO'ByrnePMInmanMD 2002 Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia. Am J Physiol Lung Cell Mol Physiol 282 L833 839

35. MoXYSarawarSRDohertyPC 1995 Induction of cytokines in mice with parainfluenza pneumonia. J Virol 69 1288 1291

36. TashiroMPritzerEKhoshnanMAYamakawaMKurodaK 1988 Characterization of a pantropic variant of Sendai virus derived from a host range mutant. Virology 165 577 583

37. MiyamaeT 2005 Differential invasion by Sendai virus of abdominal parenchymal organs and brain tissues in cortisone- and cyclophosphamide-based immunosuppressed mice. J Vet Med Sci 67 369 377

38. KiyotaniKSakaguchiTFujiiYYoshidaT 1993 F0-containing noninfectious Sendai virus can initiate replication in mouse lungs but requires a relatively long incubation period. J Virol 67 7618 7622

39. ReichelderferTEChanockRMCraigheadJEHuebnerRJTurnerHC 1958 Infection of human volunteers with type 2 hemadsorption virus. Science 128 779 780

40. BrownsteinDG 1987 Resistance/susceptibility to lethal Sendai virus infection genetically linked to a mucociliary transport polymorphism. J Virol 61 1670 1671

41. BrownsteinDGSmithALJohnsonEA 1981 Sendai virus infection in genetically resistant and susceptible mice. Am J Pathol 105 156 163

42. BrownsteinDGWinklerS 1986 Genetic resistance to lethal Sendai virus pneumonia: virus replication and interferon production in C57BL/6J and DBA/2J mice. Lab Anim Sci 36 126 129

43. FaiscaPAnhDBDesmechtDJ 2005 Sendai virus-induced alterations in lung structure/function correlate with viral loads and reveal a wide resistance/susceptibility spectrum among mouse strains. Am J Physiol Lung Cell Mol Physiol 289 L777 787

44. HallCBDouglasRGJr 1981 Modes of transmission of respiratory syncytial virus. J Pediatr 99 100 103

45. McLeanDMBannatyneRMGivanKF 1967 Myxovirus dissemination by air. Can Med Assoc J 96 1449 1453

46. LowenACMubarekaSSteelJPaleseP 2007 Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog 3 1470 1476

47. AndersonDEvon MesslingV 2008 Region between the canine distemper virus M and F genes modulates virulence by controlling fusion protein expression. J Virol 82 10510 10518

48. LuqueLEBridgesOAMasonJNBoydKLPortnerA 2010 Residues in the heptad repeat A region of the fusion protein modulate the virulence of Sendai virus in mice. J Virol 84 810 821

49. BousseTMatrosovichTPortnerAKatoANagaiY 2002 The long noncoding region of the human parainfluenza virus type 1 f gene contributes to the read-through transcription at the m-f gene junction. J Virol 76 8244 8251

50. SpriggsMKCollinsPL 1986 Human parainfluenza virus type 3: messenger RNAs, polypeptide coding assignments, intergenic sequences, and genetic map. J Virol 59 646 654

51. RassaJCParksGD 1998 Molecular basis for naturally occurring elevated readthrough transcription across the M-F junction of the paramyxovirus SV5. Virology 247 274 286

52. CattaneoRRebmannGBaczkoKter MeulenVBilleterMA 1987 Altered ratios of measles virus transcripts in diseased human brains. Virology 160 523 526

53. TouzeletOLoukiliNPeletTFairleyDCurranJ 2009 De novo generation of a non-segmented negative strand RNA virus with a bicistronic gene. Virus Res 140 40 48

54. von MesslingVMilosevicDCattaneoR 2004 Tropism illuminated: lymphocyte-based pathways blazed by lethal morbillivirus through the host immune system. Proc Natl Acad Sci U S A 101 14216 14221

55. RuddPACattaneoRvon MesslingV 2006 Canine distemper virus uses both the anterograde and the hematogenous pathway for neuroinvasion. J Virol 80 9361 9370

56. LemonKde VriesRDMesmanAWMcQuaidSvan AmerongenG 2011 Early target cells of measles virus after aerosol infection of non-human primates. PLoS Pathog 7 e1001263

57. de SwartRLLudlowMde WitteLYanagiYvan AmerongenG 2007 Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog 3 e178

58. ZhangLBukreyevAThompsonCIWatsonBPeeplesME 2005 Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. J Virol 79 1113 1124

59. VillenaveRTouzeletOThavagnanamSSarlangSParkerJ 2010 Cytopathogenesis of Sendai virus in well-differentiated primary pediatric bronchial epithelial cells. J Virol 84 11718 11728

60. HallCBDouglasRGJrSchnabelKCGeimanJM 1981 Infectivity of respiratory syncytial virus by various routes of inoculation. Infect Immun 33 779 783

61. ParrottRHKimHWBrandtCDChanockRM 1975 Potential of attenuated respiratory syncytial virus vaccine for infants and children. Dev Biol Stand 28 389 399

62. TyrrellDABynoeMLPetersenKBSuttonRNPereiraMS 1959 Inoculation of human volunteers with parainfluenza viruses types 1 and 3 (HA 2 and HA 1). Br Med J 2 909 911

63. StephensHA 2010 HLA and other gene associations with dengue disease severity. Curr Top Microbiol Immunol 338 99 114

64. ZhangLKatzJMGwinnMDowlingNFKhouryMJ 2009 Systems-based candidate genes for human response to influenza infection. Infect Genet Evol 9 1148 1157

65. ArkwrightPDAbinunM 2008 Recently identified factors predisposing children to infectious diseases. Curr Opin Infect Dis 21 217 222

66. SimonAYMoritohKTorigoeDAsanoASasakiN 2009 Multigenic control of resistance to Sendai virus infection in mice. Infect Genet Evol 9 1253 1259

67. BoonACdeBeauchampJHollmannALukeJKotbM 2009 Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice. J Virol 83 10417 10426

68. AnhDBFaiscaPDesmechtDJ 2006 Differential resistance/susceptibility patterns to pneumovirus infection among inbred mouse strains. Am J Physiol Lung Cell Mol Physiol 291 L426 435

69. ItohTIwaiHUedaK 1991 Comparative lung pathology of inbred strain of mice resistant and susceptible to Sendai virus infection. J Vet Med Sci 53 275 279

70. StarkJMMcDowellSAKoenigsknechtVProwsDRLeikaufJE 2002 Genetic susceptibility to respiratory syncytial virus infection in inbred mice. J Med Virol 67 92 100

71. KidoHYokogoshiYSakaiKTashiroMKishinoY 1992 Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein. J Biol Chem 267 13573 13579

72. TashiroMYokogoshiYTobitaKSetoJTRottR 1992 Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity. J Virol 66 7211 7216

73. ZurcherCBurekJDVan NunenMCMeihuizenSP 1977 A naturally occurring epizootic caused by Sendai virus in breeding and aging rodent colonies. I. Infection in the mouse. Lab Anim Sci 27 955 962

74. ProfetaMLLiefFSPlotkinSA 1969 Enzootic sendai infection in laboratory hamsters. Am J Epidemiol 89 316 324

75. BhattPNJonasAM 1974 An epizootic of Sendai infection with mortality in a barrier-maintained mouse colony. Am J Epidemiol 100 222 229

76. IshidaNHommaM 1978 Sendai virus. Adv Virus Res 23 349 383

77. NakagawaMSaitoMKinoshitaKSuzukiEImaizumiK 1980 Pathogenicity of Sendai virus in mice cage-mated with infectors and their offsprings. Nippon Juigaku Zasshi 42 337 344

78. SakaguchiTKiyotaniKSakakiMFujiiYYoshidaT 1994 A field isolate of Sendai virus: its high virulence to mice and genetic divergence form prototype strains. Arch Virol 135 159 164

79. ItohMIsegawaYHottaHHommaM 1997 Isolation of an avirulent mutant of Sendai virus with two amino acid mutations from a highly virulent field strain through adaptation to LLC-MK2 cells. J Gen Virol 78 Pt 12 3207 3215

80. KiyotaniKSakaguchiTFujiiYYoshidaT 2001 Attenuation of a field Sendai virus isolate through egg-passages is associated with an impediment of viral genome replication in mouse respiratory cells. Arch Virol 146 893 908

81. GarcinDItohMKolakofskyD 1997 A point mutation in the Sendai virus accessory C proteins attenuates virulence for mice, but not virus growth in cell culture. Virology 238 424 431

82. FujiiYSakaguchiTKiyotaniKHuangCFukuharaN 2002 Involvement of the leader sequence in Sendai virus pathogenesis revealed by recovery of a pathogenic field isolate from cDNA. J Virol 76 8540 8547

83. SakaguchiTKiyotaniKWatanabeHHuangCFukuharaN 2003 Masking of the contribution of V protein to Sendai virus pathogenesis in an infection model with a highly virulent field isolate. Virology 313 581 587

84. SkiadopoulosMHSurmanSRRiggsJMElkinsWRSt ClaireM 2002 Sendai virus, a murine parainfluenza virus type 1, replicates to a level similar to human PIV1 in the upper and lower respiratory tract of African green monkeys and chimpanzees. Virology 297 153 160

85. BousseTChambersRLScroggsRAPortnerATakimotoT 2006 Human parainfluenza virus type 1 but not Sendai virus replicates in human respiratory cells despite IFN treatment. Virus Res 121 23 32

86. SkiadopoulosMHSurmanSRRiggsJMOrvellCCollinsPL 2002 Evaluation of the replication and immunogenicity of recombinant human parainfluenza virus type 3 vectors expressing up to three foreign glycoproteins. Virology 297 136 152

87. LuqueLERussellCJ 2007 Spring-loaded heptad repeat residues regulate the expression and activation of paramyxovirus fusion protein. J Virol 81 3130 3141